The first Myriad Genetics trade was made in Q1 2013.
Since then Ron Baron bought shares nine more times and sold shares on four occasions. The investor completely sold their stake between Q3 2019 and Q4 2019.
Avg closing price
Price range
Sold -285 Thousand shares
Q4 2019
Avg closing price
$27.51
Price range
$20.93
-
$35.10
Sold 47.7% shares (-260 Thousand shares)
Q3 2019
Avg closing price
$29.14
Price range
$22.08
-
$47.08
Increased shares by 7.0% (+35.4 Thousand shares)
Q2 2019
Avg closing price
$28.24
Price range
$22.67
-
$35.00
Increased shares by 38.6% (+142 Thousand shares)
Q1 2019
Avg closing price
$30.44
Price range
$26.93
-
$34.70
Increased shares by 41.4% (+108 Thousand shares)
Q4 2018
Avg closing price
$35.97
Price range
$27.23
-
$45.56
Increased shares by 8.3% (+20 Thousand shares)
Q2 2018
Avg closing price
$33.78
Price range
$27.75
-
$40.17
Increased shares by 29.7% (+55 Thousand shares)
Q1 2018
Avg closing price
$33.84
Price range
$28.83
-
$41.01
Sold 14.2% shares (-30.5 Thousand shares)
Q4 2017
Avg closing price
$33.74
Price range
$28.45
-
$37.14
Increased shares by 57.9% (+79 Thousand shares)
Q2 2017
Avg closing price
$21.23
Price range
$17.61
-
$26.47
Increased shares by 70.6% (+56.5 Thousand shares)
Q1 2017
Avg closing price
$17.72
Price range
$15.40
-
$19.67
Increased shares by 100.0% (+40 Thousand shares)
Q4 2016